Sihuan Pharmaceutical Holdings Group Ltd. (FRA:TEL1)

Market Cap	772.98M -48.5%
Revenue (ttm)	339.28M +25.5%
Net Income	38.89M
EPS	0.00
Shares Out	n/a
PE Ratio	18.56
Forward PE	n/a
Dividend	0.00 (1.49%)
Ex-Dividend Date	Jun 30, 2026

Volume	1,000
Open	0.0815
Previous Close	0.0785
Day's Range	0.0815 - 0.0820
52-Week Range	0.0770 - 0.1810
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About FRA:TEL1

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invas...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,712
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEL1

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error